AniCura, a leader in high quality veterinary care for companion animals, has established the AniCura Research Fund together with three of its owners (the Animal Hospital Foundation in Greater Stockholm, Fidelio Capital and Nordic Capital). The purpose of the fund is to support clinical research within the veterinary medicine field and the AniCura Research Fund has now decided to award grants to five different projects.
The AniCura Research Fund was established in March 2015 to provide more funds to the clinical research being performed by AniCura employees. The application process for 2015 research grants was recently concluded. AniCura’s Scientific Council have reviewed all applications to make sure that the projects have a sufficiently high scientific level and quality and that they have the chance to bring about new knowledge within veterinary medicine.
”It is truly gratifying that there is a real interest for research within AniCura, and that we have received so many applications for current or future research projects. It can be challenging to conduct clinical research alongside with everyday work, and therefore the initiative around AniCura’s Research Fund is especially positive to help create the right circumstances.” says Anna Tidholm, Chairman of AniCura’s Scientific Council, DVM, PhD, Associate Professor and Dipl ECVIM-CA (Cardiology).
The following five veterinary medical research projects have been awarded financial supports from AniCura’s Research Fund in 2015, of which four are from Sweden and one from Denmark:
- “Development of mitral insufficiency in the Norfolk Terrier”, Anna Bodegård, DVM, MD, Anicura Albano Djursjukhus, Stockholm, Sweden
- “Gene therapy for dogs with epilepsy: The first clinical trials”, Rikke Fast, DVM, PhD, AniCura Aarhus Dyrehospital, Aarhus, Denmark
- “Phenotypic classification of breed related myelopathies in Pugs”, Cecilia Rohdin, DVM, Dipl ECVN, AniCura Albano Djursjukhus, Stockholm, Sweden
- “Seroprevalence of tick-borne encephalitis virus (TBEV) antibodies in clinical healthy dogs in South-east Sweden”, Mikael Svensson, DVM, AniCura Läckeby Djursjukhus, Kalmar, Sweden
- “Evaluation of whole blood hemostasis with thromboelastography in Cavalier King Charles Spaniels with different severities of myxomatous mitral valve disease”, Josefine Öberg, DVM, Dipl ECVCP, AniCura Regiondjursjukhuset Bagarmossen, Stockholm, Sweden
”Since the creation of AniCura we have had high ambitions in the area of veterinary medicine. One of many examples is our support of clinical research in veterinary medicine, coupled by our significant investments in equipment and education enabling us to offer modern and specialized veterinary care on the frontier of veterinary medical development. Our initiative of the AniCura Research Fund further underlines this ambition, and we look forward to supporting high quality clinical research for many years to come.” says Peter Dahlberg, AniCura CEO.
For more information, please contact
Anna Tidholm, AniCura Djursjukhuset Albano, +46-8-505 304 00
Peter Dahlberg, CEO, +46-8-755 00 00